Skip to content
National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Division of Cancer Prevention logo
Home Site Map Contact DCP
Programs & Resources

Prostate and Urologic Cancer Research Group

Programs and Projects

Grants and Contracts Portfolio

Search the NCI-Funded Research Portfolio for projects supported by the Prostate and Urologic Cancer Research Group. Use the Advanced Search to choose Division of Cancer Prevention and a topic or program director name.

Bladder Cancer Clinical Trials


Principal Investigator Funding Mechanism Title of Award Chemopreventive Agent
Howard Bailey, MD
University of Wisconsin
Phase I/II Consortia ContractEvaluating the potential of Polyphenon E, a green tea polyphenol extract, as a chemopreventive agent for bladder cancerPolyphenon E

Prostate Cancer Clinical Trials


Principal Investigator Funding Mechanism Title of Award Chemopreventive Agent
Nagi Kumar, Ph.D
H. Lee Moffitt Cancer Center and Research

R01 Phase II Trial of Polyphenone E in Prostate CancerPolyphenon E
Michael Gaziano, MD
Brigham and Women’s Hospital

R01 Physicians' Health Study II: Vitamin E, Ascorbic Acid, Beta Carotene, and/or Multivitamins in Preventing Cancer and Cardiovascular Disease in Older Healthy Male DoctorsVitamin E, C & Multivitamin
Sherry Chow, PhD
University of Arizona
Phase I/II Consortia Contract Bioavailability of metformin in prostate tissue in pre-prostatectomy men. Metformin

Howard Bailey, MD
University of Wisconsin

Phase I/II Consortia Contract Effects of pomegranate fruit extract on plasma levels of insulin-like growth factor in men with early prostate cancer. Pomegranate fruit extract
Jeri Kim, MD
University of Texas M. D. Anderson
Phase I/II Consortia Contract The effects of finasteride on the grade of prostate tumors. Finasteride

Skin Cancer Clinical Trials


Principal Investigator Funding Mechanism Title of Award Chemopreventive Agent
Howard Bailey, MD
University of Wisconsin
Phase I/II Consortia Contract Evaluation of a novel retinoid (9cUAB30) as a chemopreventive agent for nonmelanoma skin cancer 9cUAB30
H-H. Sherry Chow, PhD
University of Arizona
Phase I/II Consortia Contract
Sulindac in Preventing Skin Cancer in Healthy Participants Who Are at Increased RiskSulindac


Back to top